Holocene Advisors
ACAD icon

Holocene Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Holocene Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,607
Closed -$713K – 787
2022
Q2 		$713K Buy
+50,607
New +$944K ﹤0.01% 687
2021
Q2 		– Hold
0
– – – 811
2021
Q1 		– Hold
0
– – – 780
2018
Q2 		– Sell
-10,047
Closed -$226K – 562
2018
Q1 		$226K Sell
10,047
-1,021
-9% -$28.3K 0.01% 494
2017
Q4 		$333K Buy
+11,068
New +$354K 0.01% 517

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return